TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma
ERYtech Pharma
Pascal Hammel; Jean-Philippe Metges; Teresa Macarulla Mercade; Rocio Garcia-Carbonero; Olivier Bouché; Fabienne Portales; Roberto A Pazo Cid; Laurent Mineur; Antonio Cubillo Gracian; Isabelle Trouilloud; Rosine Guimbaud; David Tougeron; Juan Jose Reina; Jaime Feliu; Tamara Sauri; Christos Fountzilas; Thierry Lecomte; Yann Molin; Mariano Ponz-Sarvise; Frederic Forget; Rossana Berardi; Eric Van Cutsem; Fabio Gelsomino; Christophe Tournigand; Bruno Bockorny; Jean Baptiste Bachet; Miguel Marin Vera; Pieter-Jan Cuyle; Harpreet Wasan; Marcus Noel; Jean-Luc Van Laethem; Richard Kay; Hagop Youssoufian; Iman El-Hariry; Manuel Hidalgo
RK Statistics Ltd, Bakewell, United Kingdom.